On Oct. 17, the Food and Drug Administration (FDA) announced that it has awarded more than $23 million in research grants over the next 4 years to boost the development of products for patients with rare diseases. Read more
FDA grants to stimulate product development for rare diseases
*Online Bonus Content: This has not been peer reviewed. The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal.
